Global Oncolytic Virus Immunotherapy Market Size, Status and Forecast 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Oncolytic Virus Immunotherapy Revenue
• 1.4 Market by Type
  • 1.4.1 Global Oncolytic Virus Immunotherapy Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Engineering Oncolytic Viruses
  • 1.4.3 Wild-Type Oncolytic Viruses
• 1.5 Market by Application
  • 1.5.1 Global Oncolytic Virus Immunotherapy Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals
  • 1.5.3 Clinics
  • 1.5.4 Ambulatory Surgical Centers
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Oncolytic Virus Immunotherapy Market Perspective (2015-2026)
• 2.2 Global Oncolytic Virus Immunotherapy Growth Trends by Regions
  • 2.2.1 Oncolytic Virus Immunotherapy Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Oncolytic Virus Immunotherapy Historic Market Share by Regions (2015-2020)
  • 2.2.3 Oncolytic Virus Immunotherapy Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Oncolytic Virus Immunotherapy Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Oncolytic Virus Immunotherapy Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Oncolytic Virus Immunotherapy Players by Market Size
  • 3.1.1 Global Top Oncolytic Virus Immunotherapy Players by Revenue (2015-2020)
  • 3.1.2 Global Oncolytic Virus Immunotherapy Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Oncolytic Virus Immunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Oncolytic Virus Immunotherapy Market Concentration Ratio
  • 3.2.1 Global Oncolytic Virus Immunotherapy Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Oncolytic Virus Immunotherapy Revenue in 2019
• 3.3 Oncolytic Virus Immunotherapy Key Players Head office and Area Served
• 3.4 Key Players Oncolytic Virus Immunotherapy Product Solution and Service
• 3.5 Date of Enter into Oncolytic Virus Immunotherapy Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Oncolytic Virus Immunotherapy Historic Market Size by Type (2015-2020)
• 4.2 Global Oncolytic Virus Immunotherapy Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Oncolytic Virus Immunotherapy Market Size by Application (2015-2020)
• 5.2 Global Oncolytic Virus Immunotherapy Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Oncolytic Virus Immunotherapy Market Size (2015-2020)
• 6.2 Oncolytic Virus Immunotherapy Key Players in North America (2019-2020)
• 6.3 North America Oncolytic Virus Immunotherapy Market Size by Type (2015-2020)
• 6.4 North America Oncolytic Virus Immunotherapy Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Oncolytic Virus Immunotherapy Market Size (2015-2020)
• 7.2 Oncolytic Virus Immunotherapy Key Players in Europe (2019-2020)
• 7.3 Europe Oncolytic Virus Immunotherapy Market Size by Type (2015-2020)
• 7.4 Europe Oncolytic Virus Immunotherapy Market Size by Application (2015-2020)

8 China

• 8.1 China Oncolytic Virus Immunotherapy Market Size (2015-2020)
• 8.2 Oncolytic Virus Immunotherapy Key Players in China (2019-2020)
• 8.3 China Oncolytic Virus Immunotherapy Market Size by Type (2015-2020)
• 8.4 China Oncolytic Virus Immunotherapy Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Oncolytic Virus Immunotherapy Market Size (2015-2020)
• 9.2 Oncolytic Virus Immunotherapy Key Players in Japan (2019-2020)
• 9.3 Japan Oncolytic Virus Immunotherapy Market Size by Type (2015-2020)
• 9.4 Japan Oncolytic Virus Immunotherapy Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Oncolytic Virus Immunotherapy Market Size (2015-2020)
• 10.2 Oncolytic Virus Immunotherapy Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Oncolytic Virus Immunotherapy Market Size by Type (2015-2020)
• 10.4 Southeast Asia Oncolytic Virus Immunotherapy Market Size by Application (2015-2020)

11 India

• 11.1 India Oncolytic Virus Immunotherapy Market Size (2015-2020)
• 11.2 Oncolytic Virus Immunotherapy Key Players in India (2019-2020)
• 11.3 India Oncolytic Virus Immunotherapy Market Size by Type (2015-2020)
• 11.4 India Oncolytic Virus Immunotherapy Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Oncolytic Virus Immunotherapy Market Size (2015-2020)
• 12.2 Oncolytic Virus Immunotherapy Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Oncolytic Virus Immunotherapy Market Size by Type (2015-2020)
• 12.4 Central & South America Oncolytic Virus Immunotherapy Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Merck
  • 13.1.1 Merck Company Details
  • 13.1.2 Merck Business Overview
  • 13.1.3 Merck Oncolytic Virus Immunotherapy Introduction
  • 13.1.4 Merck Revenue in Oncolytic Virus Immunotherapy Business (2015-2020))
  • 13.1.5 Merck Recent Development
• 13.2 Amgen
  • 13.2.1 Amgen Company Details
  • 13.2.2 Amgen Business Overview
  • 13.2.3 Amgen Oncolytic Virus Immunotherapy Introduction
  • 13.2.4 Amgen Revenue in Oncolytic Virus Immunotherapy Business (2015-2020)
  • 13.2.5 Amgen Recent Development
• 13.3 TILT Biotherapeutics
  • 13.3.1 TILT Biotherapeutics Company Details
  • 13.3.2 TILT Biotherapeutics Business Overview
  • 13.3.3 TILT Biotherapeutics Oncolytic Virus Immunotherapy Introduction
  • 13.3.4 TILT Biotherapeutics Revenue in Oncolytic Virus Immunotherapy Business (2015-2020)
  • 13.3.5 TILT Biotherapeutics Recent Development
• 13.4 Oncorus
  • 13.4.1 Oncorus Company Details
  • 13.4.2 Oncorus Business Overview
  • 13.4.3 Oncorus Oncolytic Virus Immunotherapy Introduction
  • 13.4.4 Oncorus Revenue in Oncolytic Virus Immunotherapy Business (2015-2020)
  • 13.4.5 Oncorus Recent Development
• 13.5 Sorrento Therapeutics
  • 13.5.1 Sorrento Therapeutics Company Details
  • 13.5.2 Sorrento Therapeutics Business Overview
  • 13.5.3 Sorrento Therapeutics Oncolytic Virus Immunotherapy Introduction
  • 13.5.4 Sorrento Therapeutics Revenue in Oncolytic Virus Immunotherapy Business (2015-2020)
  • 13.5.5 Sorrento Therapeutics Recent Development
• 13.6 Shanghai Sunway Biotech
  • 13.6.1 Shanghai Sunway Biotech Company Details
  • 13.6.2 Shanghai Sunway Biotech Business Overview
  • 13.6.3 Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Introduction
  • 13.6.4 Shanghai Sunway Biotech Revenue in Oncolytic Virus Immunotherapy Business (2015-2020)
  • 13.6.5 Shanghai Sunway Biotech Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer